279 related articles for article (PubMed ID: 12821780)
1. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.
Girnita L; Girnita A; Larsson O
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8247-52. PubMed ID: 12821780
[TBL] [Abstract][Full Text] [Related]
2. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
[TBL] [Abstract][Full Text] [Related]
3. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
5. IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Oncogene; 2022 Jan; 41(4):600-611. PubMed ID: 34785779
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of p53 inhibits its ubiquitination by Mdm2.
Li M; Luo J; Brooks CL; Gu W
J Biol Chem; 2002 Dec; 277(52):50607-11. PubMed ID: 12421820
[TBL] [Abstract][Full Text] [Related]
7. A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop.
Xiong L; Kou F; Yang Y; Wu J
J Cell Biol; 2007 Sep; 178(6):995-1007. PubMed ID: 17846171
[TBL] [Abstract][Full Text] [Related]
8. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 by Mdm2: fate is in the numbers.
Shmueli A; Oren M
Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 association with p53 targets its ubiquitination.
Fuchs SY; Adler V; Buschmann T; Wu X; Ronai Z
Oncogene; 1998 Nov; 17(19):2543-7. PubMed ID: 9824166
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
12. MDM2 promotes ubiquitination and degradation of MDMX.
Pan Y; Chen J
Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
[TBL] [Abstract][Full Text] [Related]
13. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage.
Héron-Milhavet L; LeRoith D
J Biol Chem; 2002 May; 277(18):15600-6. PubMed ID: 11877395
[TBL] [Abstract][Full Text] [Related]
15. Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.
Waraky A; Lin Y; Warsito D; Haglund F; Aleem E; Larsson O
J Biol Chem; 2017 Nov; 292(44):18227-18239. PubMed ID: 28924044
[TBL] [Abstract][Full Text] [Related]
16. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation.
Zaika A; Marchenko N; Moll UM
J Biol Chem; 1999 Sep; 274(39):27474-80. PubMed ID: 10488081
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
[TBL] [Abstract][Full Text] [Related]
19. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
[TBL] [Abstract][Full Text] [Related]
20. Effects of MdmX on Mdm2-mediated downregulation of pRB.
Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
